A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

Sara Penuela Rodriguez (left), an interdisciplinary neuroscience doctoral student, administers infrared laser light therapy ...

Brenig Therapeutics, a clinical-stage biotechnology company pioneering AI-powered small-molecule therapies for ...

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

Paul Sinha, best known as 'The Sinnerman' on ITV show The Chase, opened up about his health challenges ahead of his return to ...

The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.

Public Health Specialist An emerging body of research suggests that Parkinson’s disease (PD) may be significantly underdiagnosed within Zimbabwe’s ageing population.

Muscle stiffness, or rigidity, is another common early sign. It can happen in the arms, legs, or body and may feel like ...

In those nations, MAID is available to a wider universe of pained people, not just those with fewer than six months to live.